Veeva Systems
- Home ›
- US ›
- Healthcare
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, and internationally. The last earnings update was 23 days ago. More info.
Add to Portfolio Compare Print
- Veeva Systems has significant price volatility in the past 3 months.
VEEV Share Price and Events
7 Day Returns
1 Year Returns
VEEV Shareholder Return
| 7 Day | 30 Day | 90 Day | 1 Year | 3 Year | 5 Year | |
|---|---|---|---|---|---|---|
| Veeva Systems (VEEV) | 1.8% | 3.5% | 53.8% | 65.9% | 404.1% | 379.1% |
| US Healthcare Services | 1.7% | -0.7% | 19.3% | 21.4% | 62.8% | 24.4% |
| US Market | 1.2% | 2.1% | 14.6% | 3% | 39% | 43.5% |
1 Year Return vs Industry and Market
- VEEV outperformed the Healthcare Services industry which returned 21.4% over the past year.
- VEEV outperformed the Market in United States of America which returned 3% over the past year.
VEEV Value
Is Veeva Systems undervalued based on future cash flows and its price relative to the stock market?
Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current
share
price of
Veeva Systems
to its discounted cash flow analysis.value.The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Below are the data sources, inputs and calculation used to determine the intrinsic value for Veeva Systems.
| Data Point | Source | Value |
|---|---|---|
| Valuation Model | 2 Stage Free Cash Flow to Equity | |
| Levered Free Cash Flow | Average of 17 Analyst Estimates (S&P Global) | See below |
| Discount Rate (Cost of Equity) | See below | 9.6% |
| Perpetual Growth Rate | 10-Year US Government Bond Rate | 2.7% |
An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.
| Data Point | Calculation/ Source | Result |
|---|---|---|
| Risk-Free Rate | 10-Year US Govt Bond Rate | 2.7% |
| Equity Risk Premium | S&P Global | 6% |
| Healthcare Services Unlevered Beta | Simply Wall St/ S&P Global | 1.22 |
| Re-levered Beta | = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 1.221 (1 + (1- 21%) (0%)) |
1.148 |
| Levered Beta | Levered Beta limited to 0.8 to 2.0 (practical range for a stable firm) |
1.15 |
| Discount Rate/ Cost of Equity |
= Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.73% + (1.148 * 5.96%) |
9.57% |
Discounted Cash Flow Calculation for NYSE:VEEV using 2 Stage Free Cash Flow to Equity Model
The calculations below outline how an intrinsic value for Veeva Systems is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.
| Levered FCF (USD, Millions) | Source |
Present Value Discounted (@ 9.57%) |
|
|---|---|---|---|
| 2019 | 284.19 | Analyst x10 | 259.36 |
| 2020 | 343.08 | Analyst x11 | 285.75 |
| 2021 | 422.87 | Analyst x11 | 321.44 |
| 2022 | 497.04 | Analyst x3 | 344.82 |
| 2023 | 564.95 | Analyst x2 | 357.68 |
| 2024 | 651.80 | Analyst x2 | 376.62 |
| 2025 | 721.64 | Est @ 10.72% | 380.55 |
| 2026 | 781.69 | Est @ 8.32% | 376.20 |
| 2027 | 833.61 | Est @ 6.64% | 366.14 |
| 2028 | 879.20 | Est @ 5.47% | 352.43 |
| Present value of next 10 years cash flows | $3,420.98 | ||
| Calculation | Result | |
|---|---|---|
| Terminal Value |
= FCF2028
× (1 + g) ÷ (Discount Rate – g)
= $879.20 × (1 + 2.73%) ÷ (9.57% – 2.73%) |
$13,199.77 |
| Present Value of Terminal Value |
= Terminal Value ÷ (1 + r)10
= $13,199.77 ÷ (1 + 9.57%)10 |
$5,291.12 |
| Calculation | Result | |
|---|---|---|
| Total Equity Value |
= Present value of next 10 years cash flows +
Terminal Value
= $3,420.98 + $5,291.12 |
$8,712.10 |
| Equity Value per Share (USD) |
= Total value / Shares Outstanding
= $8,712.10 / 145.30 |
$59.96 |
| Calculation | Result | |
|---|---|---|
| Value per share (USD) | From above. | $59.96 |
| Current discount | Discount to share price of
$124.57
= -1 x ($124.57 - $59.96) / $59.96 |
-107.8% |
Learn more about our DCF calculations in Simply Wall St’s analysis model .
- The current share price of Veeva Systems is above its future cash flow value.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.The amount the stock market is willing to pay for Veeva Systems's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are
Veeva Systems's earnings available for a low price, and how does
this compare to other companies in the same industry?
| Data Point | Source | Value |
|---|---|---|
| Earnings Per Share * | Company Filings (2019-01-31) in USD | $1.59 |
| NYSE:VEEV Share Price ** | NYSE (2019-03-20) in USD | $124.57 |
| United States of America Healthcare Services Industry PE Ratio | Median Figure of 14 Publicly-Listed Healthcare Services Companies | 73.33x |
| United States of America Market PE Ratio | Median Figure of 3,058 Publicly-Listed Companies | 17.69x |
* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.
** Primary Listing of Veeva Systems.
| Calculation | Outcome | |
|---|---|---|
| PE Ratio | = NYSE:VEEV Share Price ÷ EPS (both in USD) = 124.57 ÷ 1.59 |
78.18x |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Veeva Systems is overvalued based on earnings compared to the US Healthcare Services industry average.
- Veeva Systems is overvalued based on earnings compared to the United States of America market.
Price based on expected Growth
Does
Veeva Systems's expected growth come at a high price?
| Data Point | Source | Value |
|---|---|---|
| PE Ratio | See PE Ratio Section | 78.18x |
| Net Income Annual Growth Rate | See Future Growth Section. Line of Best Fit* through Consensus Estimate Earnings of 17 Analysts |
13.8%per year |
| United States of America Healthcare Services Industry PEG Ratio | Median Figure of 13 Publicly-Listed Healthcare Services Companies | 2.94x |
| United States of America Market PEG Ratio | Median Figure of 2,103 Publicly-Listed Companies | 1.48x |
*Line of best fit is calculated by linear regression .
| Calculation | Outcome | |
|---|---|---|
| PEG Ratio | = PE Ratio ÷ Net Income Annual Growth Rate = 78.18x ÷ 13.8% |
5.68x |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Veeva Systems is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on
Veeva Systems's
assets?
| Data Point | Source | Value |
|---|---|---|
| Book Value per Share | Company Filings (2019-01-31) in USD | $8.50 |
| NYSE:VEEV Share Price * | NYSE (2019-03-20) in USD | $124.57 |
| United States of America Healthcare Services Industry PB Ratio | Median Figure of 35 Publicly-Listed Healthcare Services Companies | 4.39x |
| United States of America Market PB Ratio | Median Figure of 5,156 Publicly-Listed Companies | 1.89x |
| Calculation | Outcome | |
|---|---|---|
| PB Ratio | = NYSE:VEEV Share Price ÷ Book Value per Share (both in USD) = 124.57 ÷ 8.50 |
14.66x |
* Primary Listing of Veeva Systems.
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Veeva Systems is overvalued based on assets compared to the US Healthcare Services industry average.
Value checks
We assess Veeva Systems's value by looking at:- Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
- Is the PE ratio less than the market average, and/ or less than the Healthcare Services industry average (and greater than 0)? (2 checks)
- Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
- Is the PB ratio less than the Healthcare Services industry average (and greater than 0)? (1 check) Veeva Systems has a total score of 0/6, see the detailed checks below.
Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.
Full details on the Value part of the Simply Wall St company analysis model.
VEEV Future Performance
The future performance of a company is measured in the same way as past
performance, by looking at estimated
growth
and how much profit it is expected to make.Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Earnings growth vs Low Risk Savings
- Veeva Systems's earnings growth is expected to exceed the low risk savings rate of 2.7%.
Growth vs Market Checks
- Veeva Systems's earnings growth is positive but not above the United States of America market average.
- Veeva Systems's revenue growth is expected to exceed the United States of America market average.
Annual Growth Rates Comparison
| Data Point | Source | Value (per year) |
|---|---|---|
| NYSE:VEEV Future Earnings Growth Rate | Line of Best Fit* through Consensus Estimate Earnings of 17 Analysts | 13.8% |
| NYSE:VEEV Future Revenue Growth Rate | Line of Best Fit* through Consensus Estimate Revenue of 17 Analysts | 15.1% |
| United States of America Healthcare Services Industry Earnings Growth Rate | Market Cap Weighted Average | 21.9% |
| United States of America Healthcare Services Industry Revenue Growth Rate | Market Cap Weighted Average | 11.7% |
| United States of America Market Earnings Growth Rate | Market Cap Weighted Average | 14.3% |
| United States of America Market Revenue Growth Rate | Market Cap Weighted Average | 7.1% |
*Line of best fit is calculated by linear regression .
Industry and Market average data is calculated daily.
Learn more about our growth rate calculations in Simply Wall St’s analysis model.
Analysts growth expectations
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (1 month ago) | See Below |
| Future Estimates | Average of up to 17 Analyst Estimates (S&P Global) | See Below |
| Date (Data in USD Millions) | Revenue | Cash Flow | Net Income * | Avg. No. Analysts |
|---|---|---|---|---|
| 2024-01-31 | 1,998 | 645 | 523 | 2 |
| 2023-01-31 | 1,708 | 560 | 431 | 2 |
| 2022-01-31 | 1,435 | 514 | 371 | 6 |
| 2021-01-31 | 1,218 | 430 | 297 | 16 |
| 2020-01-31 | 1,031 | 352 | 253 | 17 |
| Date (Data in USD Millions) | Revenue | Cash Flow | Net Income * |
|---|---|---|---|
| 2019-01-31 | 862 | 311 | 230 |
| 2018-10-31 | 811 | 280 | 190 |
| 2018-07-31 | 763 | 271 | 161 |
| 2018-04-30 | 721 | 242 | 149 |
| 2018-01-31 | 686 | 233 | 142 |
| 2017-10-31 | 655 | 230 | 132 |
| 2017-07-31 | 620 | 223 | 119 |
| 2017-04-30 | 584 | 177 | 93 |
| 2017-01-31 | 544 | 144 | 69 |
| 2016-10-31 | 508 | 150 | 65 |
| 2016-07-31 | 472 | 144 | 54 |
| 2016-04-30 | 439 | 148 | 54 |
*GAAP earnings excluding extraordinary items.
Past and Future Earnings per Share
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (1 month ago) | See Below |
| Future Estimates | Average of up to 17 Analyst Estimates (S&P Global) | See Below |
All data from Veeva Systems Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in USD Millions) | EPS * | EPS High Estimate | EPS Low Estimate | Avg. No. Analysts |
|---|---|---|---|---|
| 2024-01-31 | 3.04 | 3.04 | 3.04 | 1.00 |
| 2023-01-31 | 2.55 | 2.55 | 2.55 | 1.00 |
| 2022-01-31 | 2.24 | 2.32 | 2.16 | 2.00 |
| 2021-01-31 | 1.86 | 2.19 | 1.68 | 8.00 |
| 2020-01-31 | 1.62 | 1.96 | 1.40 | 9.00 |
| Date (Data in USD Millions) | EPS * |
|---|---|
| 2019-01-31 | 1.59 |
| 2018-10-31 | 1.33 |
| 2018-07-31 | 1.13 |
| 2018-04-30 | 1.06 |
| 2018-01-31 | 1.01 |
| 2017-10-31 | 0.95 |
| 2017-07-31 | 0.86 |
| 2017-04-30 | 0.68 |
| 2017-01-31 | 0.51 |
| 2016-10-31 | 0.48 |
| 2016-07-31 | 0.40 |
| 2016-04-30 | 0.41 |
*GAAP earnings excluding extraordinary items.
Future performance checks
We assess Veeva Systems's future performance by looking at:- Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
- Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
- Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
- Is the annual earnings growth rate expected to be above 20%? (1 check)
- Is the annual revenue growth rate expected to be above 20%? (1 check)
- Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Veeva Systems has a total score of 2/6, see the detailed checks below.
Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.
Full details on the Future part of the Simply Wall St company analysis model.
VEEV Past Performance
How has Veeva Systems performed over the past 5 years?
The past performance of a company can be measured by how much
growth
it has experienced and how much profit it makes relative to the funds and assets
it has available.
Past earnings growth
Past Earnings growth analysis
- Veeva Systems has delivered over 20% year on year earnings growth in the past 5 years.
- Veeva Systems's 1-year earnings growth exceeds its 5-year average (61.9% vs 43.7%)
- Veeva Systems's earnings growth has exceeded the US Healthcare Services industry average in the past year (61.9% vs 39.9%).
Earnings and Revenue History
All data from Veeva Systems Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in USD Millions) | Revenue | Net Income * | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 2019-01-31 | 862.21 | 229.83 | 235.28 | 158.78 |
| 2018-10-31 | 810.88 | 190.12 | 226.91 | 153.05 |
| 2018-07-31 | 763.16 | 160.96 | 213.90 | 147.09 |
| 2018-04-30 | 721.35 | 149.28 | 201.81 | 140.94 |
| 2018-01-31 | 685.57 | 141.97 | 191.29 | 132.05 |
| 2017-10-31 | 654.73 | 132.23 | 182.67 | 121.13 |
| 2017-07-31 | 620.50 | 118.93 | 175.45 | 112.10 |
| 2017-04-30 | 584.05 | 93.29 | 170.57 | 102.99 |
| 2017-01-31 | 544.04 | 68.80 | 165.64 | 96.75 |
| 2016-10-31 | 508.16 | 64.68 | 158.91 | 90.75 |
| 2016-07-31 | 472.30 | 53.52 | 149.22 | 83.40 |
| 2016-04-30 | 439.06 | 53.95 | 134.88 | 75.09 |
| 2016-01-31 | 409.22 | 54.41 | 120.24 | 65.98 |
| 2015-10-31 | 381.96 | 50.12 | 104.86 | 57.62 |
| 2015-07-31 | 358.87 | 49.85 | 97.35 | 50.59 |
| 2015-04-30 | 336.42 | 45.97 | 90.88 | 45.12 |
| 2015-01-31 | 313.22 | 40.14 | 86.44 | 41.16 |
| 2014-10-31 | 289.01 | 32.64 | 82.29 | 37.27 |
| 2014-07-31 | 260.17 | 24.83 | 76.47 | 33.22 |
| 2014-04-30 | 234.08 | 16.61 | 69.76 | 29.79 |
| 2014-01-31 | 210.15 | 10.41 | 61.92 | 26.33 |
| 2013-10-31 | 187.14 | 5.76 | 51.61 | 23.16 |
| 2013-07-31 | 167.95 | 4.43 | 42.15 | 20.18 |
| 2013-04-30 | 147.83 | 7.24 | 33.90 | 17.11 |
| 2013-01-31 | 129.55 | 3.48 | 27.86 | 14.64 |
*GAAP earnings excluding extraordinary items.
Performance last year
We want to ensure a company is making the most of what it has available. This is
done by comparing the return (profit) to a company's available
funds,
assets
and
capital.
- Veeva Systems has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
- Veeva Systems used its assets more efficiently than the US Healthcare Services industry average last year based on Return on Assets.
- Veeva Systems has improved its use of capital last year versus 3 years ago (Return on Capital Employed).
Past performance checks
We assess Veeva Systems's performance over the past 5 years by checking for:- Has earnings increased in past 5 years? (1 check)
- Has the earnings growth in the last year exceeded that of the Healthcare Services industry? (1 check)
- Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
- Is the Return on Equity (ROE) higher than 20%? (1 check)
- Is the Return on Assets (ROA) above industry average? (1 check)
- Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
Veeva Systems has a total score of 5/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
Full details on the Past part of the Simply Wall St company analysis model.
VEEV Health
How is Veeva Systems's financial health and their level of debt?
A company's financial position is much like your own financial position,
it includes everything you own
(assets)
and owe
(liabilities).The boxes below represent the relative size of what makes up Veeva Systems's finances.
The net worth of a company is the difference between its assets and liabilities.
- Veeva Systems is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Veeva Systems's cash and other short term assets cover its long term commitments.
Balance sheet
Assets
Liabilities and shares
- Low level of unsold assets.
- Veeva Systems has no debt, it does not need to be covered by short term assets.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t
bad,
however if the debt is too high, or the company can’t afford to pay the interest
on its debts this may have impacts in the future.The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.
If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
All data from Veeva Systems Company Filings, last reported 1 month ago.
| Date (Data in USD Millions) | Total Equity | Total Debt | Cash & Short Term Investments |
|---|---|---|---|
| 2019-01-31 | 1,237.75 | 0.00 | 1,090.16 |
| 2018-10-31 | 1,138.31 | 0.00 | 1,051.93 |
| 2018-07-31 | 1,050.38 | 0.00 | 1,010.43 |
| 2018-04-30 | 974.44 | 0.00 | 918.31 |
| 2018-01-31 | 871.53 | 0.00 | 761.96 |
| 2017-10-31 | 818.47 | 0.00 | 758.08 |
| 2017-07-31 | 766.60 | 0.00 | 724.65 |
| 2017-04-30 | 708.90 | 0.00 | 663.92 |
| 2017-01-31 | 652.65 | 0.00 | 518.87 |
| 2016-10-31 | 605.91 | 0.00 | 510.81 |
| 2016-07-31 | 565.11 | 0.00 | 479.56 |
| 2016-04-30 | 530.55 | 0.00 | 457.44 |
| 2016-01-31 | 505.25 | 0.00 | 346.20 |
| 2015-10-31 | 473.98 | 0.00 | 339.47 |
| 2015-07-31 | 453.64 | 0.00 | 437.97 |
| 2015-04-30 | 428.95 | 0.00 | 428.51 |
| 2015-01-31 | 406.83 | 0.00 | 397.87 |
| 2014-10-31 | 381.21 | 0.00 | 392.87 |
| 2014-07-31 | 357.39 | 0.00 | 350.20 |
| 2014-04-30 | 330.29 | 0.00 | 345.50 |
| 2014-01-31 | 280.10 | 0.00 | 288.13 |
| 2013-10-31 | 270.65 | 0.00 | 273.38 |
| 2013-07-31 | 47.40 | 0.00 | 52.88 |
| 2013-04-30 | 39.93 | 0.00 | 59.20 |
| 2013-01-31 | 33.97 | 0.00 | 46.17 |
- Veeva Systems has no debt.
- Veeva Systems has not taken on any debt in the past 5 years.
- Veeva Systems has no debt, it does not need to be covered by operating cash flow.
- Veeva Systems has no debt, therefore coverage of interest payments is not a concern.
Financial health checks
We assess Veeva Systems's financial health by checking for:- Are short term assets greater than short term liabilities? (1 check)
- Are short term assets greater than long term liabilities? (1 check)
- Has the debt to equity ratio increased in the past 5 years? (1 check)
- Is the debt to equity ratio over 40%? (1 check)
- Is the debt covered by operating cash flow? (1 check)
- Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check) Veeva Systems has a total score of 6/6, see the detailed checks below.
- Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
- Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
Full details on the Health part of the Simply Wall St company analysis model.
VEEV Dividends
What is Veeva Systems's current dividend yield, its reliability and sustainability?
Dividends are regular cash payments to you from the company, similar to a
bank paying you interest on a savings account.
Annual Dividend Income
If you bought
$2,000 of
Veeva Systems
shares you are expected to receive
$0
in your first year as a dividend.
Dividend Amount
- Unable to evaluate Veeva Systems's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Veeva Systems's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not
wildly increasing/decreasing each year. This graph shows you the historical rate
to count toward your assessment of the stock.We also check to see if the dividend has increased in the past 10 years.
| Data Point | Source | Value |
|---|---|---|
| Past Annualized Dividend Yield | S&P Global Market Data | See Below |
| Past Dividends per Share | Company Filings/ Annualized Dividend Payments | See Below |
| Future Dividends per Share Estimates | Average of up to 17 Analyst Estimates (S&P Global) | See Below |
| Global Healthcare Services Industry Average Dividend Yield | Market Cap Weighted Average of 15 Stocks | 1.3% |
| United States of America Market Average Dividend Yield | Market Cap Weighted Average of 2004 Stocks | 2.5% |
| United States of America Minimum Threshold Dividend Yield | 10th Percentile | 0.8% |
| United States of America Bottom 25% Dividend Yield | 25th Percentile | 1.4% |
| United States of America Top 25% Dividend Yield | 75th Percentile | 3.6% |
Industry and Market average data is calculated daily.
Note all dividend per share amounts are annualized and not quarterly or other period.
| Date (Data in $) | Dividend per Share (annual) | Avg. No. Analysts |
|---|---|---|
| 2024-01-31 | ||
| 2023-01-31 | ||
| 2022-01-31 | ||
| 2021-01-31 | 0.00 | 1.00 |
| 2020-01-31 | 0.00 | 1.00 |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Unable to perform a dividend volatility check as Veeva Systems has not reported any payouts.
- Unable to verify if Veeva Systems's dividend has been increasing as the company has not reported any payouts.
Income/ dividend checks
We assess Veeva Systems's dividend by checking for:- Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
- Is current dividend yield above the bottom 25% of dividend payers? (1 check)
- Is current dividend yield above the top 25% of dividend payers? (1 check)
- Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
- If they have paid a dividend for 10 years has it increased in this time? (1 check)
- How sustainable is the dividend, can Veeva Systems afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks) Veeva Systems has a total score of 0/6, see the detailed checks below.
Full details on the Dividends part of the Simply Wall St company analysis model.
VEEV Management
CEO
| COMPENSATION | $88,143,333 |
| AGE | 53 |
| TENURE AS CEO | 12.2 years |
CEO Bio
Mr. Peter P. Gassner Co-founded Veeva Systems Inc. in 2007 and has been its Chief Executive Officer since January 2007. Mr. Gassner is responsible for the overall direction and management of Verticals onDemand. Mr. Gassner is a twenty year veteran of the software industry. From 2003 to 2005, Mr. Gassner served as Senior Vice President of Technology for salesforce.com where he had responsibility for building the salesforce.com platform including product, marketing and developer relations. From 1995 to 2003, Mr. Gassner served as Chief Architect, Vice President and General Manager of PeopleTools at PeopleSoft. He served as the President of Veeva Systems. Mr. Gassner began his career with IBM in relational database development and research at IBM Silicon Valley Lab and then at IBM Almaden Research Center where he had the privilege of working closely with some of the inventors of relational database technology. He is a technology leader, responsible for creating some of the most widely deployed platforms and solutions in the enterprise software. He was early pioneer in major technology shifts from mainframe to client server and the move to cloud. He has been a Director of Veeva Systems, Inc. since January 2007. He has been an Independent Director of Zoom Video Communications, Inc. since November 2015. He has been a Director of Guidewire Software, Inc. since June 2015 and its Chairman since March 2017. Mr. Gassner holds a Bachelor of Science degree in Computer Science from Oregon State University.
CEO Compensation
- Peter's compensation has increased by more than 20% in the past year.
- Peter's remuneration is higher than average for companies of similar size in United States of America.
Management Team Tenure
Average tenure and age of the Veeva Systems management team in years:
- The average tenure for the Veeva Systems management team is over 5 years, this suggests they are a seasoned and experienced team.
Management Team
Peter Gassner
Founder
$88M
53
12.2 yrs
Matt Wallach
Co-Founder & President
$300K
46
Tim Cabral
Chief Financial Officer
$258K
51
9.1 yrs
Josh Faddis
Senior VP
$874K
46
6.5 yrs
Eleni Zuppas
Chief Marketing Officer
$300K
48
6 yrs
Alan Mateo
Executive Vice President of Global Sales
$300K
56
3.9 yrs
Frederic Lequient
Senior Vice President of Global Customer Services
$794K
49
3.1 yrs
Doug Ostler
Co-Founder & VP of Products
12.2 yrs
Catherine Allshouse
Global Chief Information Officer & Head of Operations
1.2 yrs
Rick Lund
Investor Relations Director
Board of Directors Tenure
Average tenure and age of the Veeva Systems board of directors in years:
- The tenure for the Veeva Systems board of directors is about average.
Board of Directors
Gordon Ritter
Chairman of the Board
$275K
53
Peter Gassner
Founder
$88M
53
12.2 yrs
Ron Codd
Director
$262K
63
7.1 yrs
Tim Barabe
Director
$225K
65
3.5 yrs
Paul Sekhri
Director
$200K
60
4.7 yrs
Paul Chamberlain
Director
$225K
54
3.3 yrs
Mark Carges
Director
$179K
56
1.8 yrs
Who owns this company?
Recent Insider Transactions
| Announced | Type | Name | Entity | Role | Start | End | Shares | Max Price ($) | Value ($) | |
|---|---|---|---|---|---|---|---|---|---|---|
| 28. Sep 18 | Sell | Timothy Barabe | Individual | 27. Sep 18 | 27. Sep 18 | -727 | $105.00 | $-76,335 | ||
| 04. Jun 18 | Sell | Timothy Barabe | Individual | 31. May 18 | 31. May 18 | -701 | $77.54 | $-54,356 | ||
Management checks
We assess Veeva Systems's management by checking for:- Is the CEO's compensation unreasonable compared to market cap? (1 check)
- Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
- Is the average tenure of the management team less than 2 years? (1 check)
- Is the average tenure of the board of directors team less than 3 years? (1 check) Veeva Systems has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.
Note: We use the top 6 management executives and board members in our calculations.
Note 2: Insider trading include any internal stakeholders and these transactions .
Full details on the Management part of the Simply Wall St company analysis model.
VEEV News
Simply Wall St News
Why Veeva Systems Inc. (NYSE:VEEV) Could Have A Place In Your Portfolio
(NYSE:VEEV) is a stock with outstanding fundamental characteristics. … When we build an investment case, we need to look at the stock with a holistic perspective. … In the case of VEEV, it.
Simply Wall St - – Full articleHave Insiders Been Selling Veeva Systems Inc. (NYSE:VEEV) Shares This Year?
So shareholders might well want to know whether insiders have been buying or selling shares in Veeva Systems Inc. … Veeva Systems Insider Transactions Over The Last Year. … In the last twelve months, the biggest single sale by an insider was when Director Timothy Barabe sold US$76k worth of shares at a price of US$105 per share.
Simply Wall St - – Full articleAre Veeva Systems Inc.’s (NYSE:VEEV) High Returns Really That Great?
In particular, we'll consider its Return On Capital Employed (ROCE), as that can give us insight into how profitably the company is able to employ capital in its business. … What is Return On Capital Employed (ROCE)? … ROCE is a metric for evaluating how much pre-tax income (in percentage terms) a company earns on the capital invested in its business.
Simply Wall St - – Full articleVeeva Systems Shareholders Have Enjoyed A Whopping 414% Share Price Gain
(NYSE:VEEV), which saw its share price soar 414% in three years. … One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement. … Veeva Systems was able to grow its EPS at 62% per year over three years, sending the share price higher.
Simply Wall St - – Full articleWhat Does Veeva Systems Inc.'s (NYSE:VEEV) P/E Ratio Tell You?
This article is for investors who would like to improve their understanding of price to earnings ratios (P/E ratios). … How Do I Calculate Veeva Systems's Price To Earnings Ratio … Price to Earnings Ratio = Price per Share ÷ Earnings per Share (EPS)
Simply Wall St - – Full articleWhat Do Analysts Think About The Future Of Veeva Systems Inc.'s (NYSE:VEEV)?
Based on Veeva Systems Inc.'s (NYSE:VEEV) earnings update in October 2018,. … it seems that analyst expectations are fairly bearish, … the higher past 5-year average growth rate of 44%
Simply Wall St - – Full articleIs It Too Late To Buy Veeva Systems Inc. (NYSE:VEEV) At Its January Price?
(NYSE:VEEV) is considered a high growth stock. … However its last closing price of $106.03 left investors wondering whether this growth has already been factored into the share price. … If you are bullish about Veeva Systems's growth potential then you are certainly not alone
Simply Wall St - – Full articleIs Veeva Systems Inc. (NYSE:VEEV) A Financially Strong Company?
Most investors favour these big stocks due to their strong balance sheet and high market liquidity, meaning there are an abundance of stock in the public market available for trading. … These firms won’t be left high and dry if liquidity dries up, and they will be relatively unaffected by rises in interest rates. … Assessing the most recent data for VEEV, I will take you through the key ratios to measure financial health, in particular, its solvency and liquidity.
Simply Wall St - – Full articleDoes Veeva Systems Inc.'s (NYSE:VEEV) CEO Pay Reflect Performance?
First, this article will compare CEO compensation with compensation at other large companies. … How Does Peter Gassner's Compensation Compare With Similar Sized Companies. … has a market cap of US$13b, and is paying total annual CEO compensation of US$88m.
Simply Wall St - – Full articleWho Has Been Selling Veeva Systems Inc (NYSE:VEEV) Shares?
So shareholders might well want to know whether insiders have been buying or selling shares in Veeva Systems Inc (NYSE:VEEV). … That means that an insider was selling shares at below the current price (US$88.56). … Over the last year we saw more insider selling of Veeva Systems shares, than buying.
Simply Wall St - – Full articleVEEV Company Info
Description
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, and internationally. The company offers Veeva Commercial Cloud, a suite of multichannel customer relationship management applications, data solutions, and master data management solutions; and Veeva Vault, a cloud-based enterprise content management applications for managing commercial functions, including medical, sales, and marketing, as well as research and development functions, such as clinical, regulatory, quality, and safety. It also provides professional and support services in the areas of implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; technical consulting services related to data migration and systems integrations; training on its solutions; and ongoing managed services that include outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was founded in 2007 and is headquartered in Pleasanton, California.
Details
| Name: | Veeva Systems Inc. |
| VEEV | |
| Exchange: | NYSE |
| Founded: | 2007 |
| $18,100,209,100 | |
| 145,301,510 | |
| Website: | http://www.veeva.com |
| Address: |
Veeva Systems Inc. 4280 Hacienda Drive, Pleasanton, California, 94588, United States |
Listings
| Exchange Symbol | Ticker Symbol | Security | Exchange | Country | Currency | Listed on | |
|---|---|---|---|---|---|---|---|
| NYSE | VEEV | Class A Common Stock | New York Stock Exchange | US | USD | 16. Oct 2013 | |
| DB | VEE | Class A Common Stock | Deutsche Boerse AG | DE | EUR | 16. Oct 2013 | |
| LSE | 0LO3 | Class A Common Stock | London Stock Exchange | GB | USD | 16. Oct 2013 | |
| BMV | VEEV * | Class A Common Stock | Bolsa Mexicana de Valores | MX | MXN | 16. Oct 2013 |
Number of employees
Current staff
Industry
| Health Care Technology | |
| Healthcare |
Company Analysis and Financial Data Status
| Area | Date (UTC time) |
|---|---|
| Company Analysis updated: | 2019/03/21 00:45 |
| End of day share price update: | 2019/03/20 00:00 |
| Last estimates confirmation: | 2019/02/27 |
| Last earnings filing: | 2019/02/26 |
| Last earnings reported: | 2019/01/31 |
| Last annual earnings reported: | 2019/01/31 |
All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
